Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/16/2863450/0/en/Foghorn-Therapeutics-Strengthens-Financial-Leadership-with-Appointment-of-Kristian-Humer-as-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/04/09/2860383/0/en/Foghorn-Therapeutics-Presents-New-Preclinical-Data-on-Potential-First-in-Class-BRM-Selective-Inhibitor-FHD-909-and-Selective-CBP-and-Selective-EP300-Degrader-Oncology-Programs.html
https://www.globenewswire.com/news-release/2024/04/05/2858433/0/en/Foghorn-Therapeutics-to-Participate-in-Needham-s-23rd-Annual-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/26/2852216/0/en/Foghorn-to-Host-Conference-Call-and-Webcast-on-Pipeline-of-Potential-First-in-Class-Medicines-in-Conjunction-with-the-2024-AACR-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/03/07/2842094/0/en/Foghorn-Therapeutics-Provides-Financial-Update-for-2023-and-2024-Strategic-Outlook.html
https://www.globenewswire.com//news-release/2024/03/05/2840970/0/en/Foghorn-Therapeutics-to-Present-New-Preclinical-Data-at-2024-AACR-Annual-Meeting-Reflecting-Advances-with-Multiple-Potential-First-in-Class-Medicines-Including-the-Selective-Inhibi.html
https://www.globenewswire.com//news-release/2024/02/28/2836802/0/en/Foghorn-Therapeutics-to-Participate-in-Cowen-s-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/08/2825889/0/en/Foghorn-Provides-Pipeline-Update-on-FHD-909-BRM-Selective-Inhibitor.html
https://www.globenewswire.com//news-release/2024/01/08/2805289/0/en/Foghorn-Therapeutics-Highlights-Clinical-Program-Updates-and-Research-Progress-and-Provides-Strategic-Objectives-for-2024.html
https://www.globenewswire.com//news-release/2024/01/03/2803620/0/en/Foghorn-Therapeutics-Announces-CFO-Departure.html